Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 27 | $39,202 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
31 Mar 2025 16:19 | UBX | Unity Biotechnology Inc | NGUYEN ALEXANDER HIEU | CLO and Head of Ops | 27 Mar 2025 | Sale | 1,954 | 1.16 | 2,267 | D |
05 Feb 2025 16:35 | UBX | Unity Biotechnology Inc | SULLIVAN LYNNE MARIE | CFO & Head of Corp. Dev. | 04 Feb 2025 | Sale | 153 | 2.23 | 341 | D |
05 Feb 2025 16:33 | UBX | Unity Biotechnology Inc | NGUYEN ALEXANDER HIEU | CLO and Head of Ops | 04 Feb 2025 | Sale | 164 | 2.23 | 366 | D |
05 Feb 2025 16:30 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 04 Feb 2025 | Sale | 642 | 2.23 | 1,432 | D |
06 Nov 2024 16:10 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 04 Nov 2024 | Sale | 432 | 1.29 | 557 | D |
06 Nov 2024 16:10 | UBX | Unity Biotechnology Inc | SULLIVAN LYNNE MARIE | CFO & Head of Corp. Dev. | 04 Nov 2024 | Sale | 136 | 1.29 | 175 | D |
06 Nov 2024 16:10 | UBX | Unity Biotechnology Inc | NGUYEN ALEXANDER HIEU | Chief Legal Officer | 04 Nov 2024 | Sale | 149 | 1.29 | 192 | D |
06 Aug 2024 17:00 | UBX | Unity Biotechnology Inc | NGUYEN ALEXANDER HIEU | Chief Legal Officer | 02 Aug 2024 | Sale | 154 | 1.53 | 236 | D |
06 Aug 2024 17:00 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 02 Aug 2024 | Sale | 604 | 1.53 | 924 | D |
06 Aug 2024 17:00 | UBX | Unity Biotechnology Inc | SULLIVAN LYNNE MARIE | CFO & Head of Corp. Dev. | 02 Aug 2024 | Sale | 139 | 1.53 | 213 | D |
26 Jun 2024 16:05 | UBX | Unity Biotechnology Inc | NGUYEN ALEXANDER HIEU | Chief Legal Officer | 25 Jun 2024 | Sale | 78 | 1.4 | 109 | D |
26 Jun 2024 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 25 Jun 2024 | Sale | 1,214 | 1.4 | 1,700 | D |
26 Jun 2024 16:05 | UBX | Unity Biotechnology Inc | SULLIVAN LYNNE MARIE | CFO & Head of Corp. Dev. | 25 Jun 2024 | Sale | 324 | 1.4 | 454 | D |
03 May 2024 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 02 May 2024 | Sale | 603 | 1.55 | 935 | D |
05 Feb 2024 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 02 Feb 2024 | Sale | 680 | 1.71 | 1,163 | D |
31 Jan 2024 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 30 Jan 2024 | Sale | 1,183 | 1.71 | 2,023 | D |
03 Nov 2023 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 02 Nov 2023 | Sale | 589 | 1.83 | 1,078 | D |
31 Oct 2023 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 30 Oct 2023 | Sale | 1,024 | 1.9 | 1,946 | D |
15 Sep 2023 16:08 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 14 Sep 2023 | Sale | 1,246 | 2.47 | 3,078 | D |
03 Aug 2023 16:13 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 02 Aug 2023 | Sale | 581 | 2.94 | 1,708 | D |
01 Aug 2023 16:05 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 31 Jul 2023 | Sale | 1,020 | 2.86 | 2,917 | D |
27 Jun 2023 17:10 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 26 Jun 2023 | Sale | 1,177 | 3.2 | 3,766 | D |
15 Jun 2023 17:58 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 14 Jun 2023 | Sale | 1,212 | 3.39 | 4,109 | D |
03 May 2023 17:26 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 02 May 2023 | Sale | 588 | 2.17 | 1,276 | D |
02 May 2023 16:32 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 01 May 2023 | Sale | 1,020 | 2.15 | 2,193 | D |
03 Apr 2023 16:55 | UBX | Unity Biotechnology Inc | GHOSH ANIRVAN | Chief Executive Officer | 31 Mar 2023 | Sale | 1,959 | 1.7 | 3,330 | D |
03 Apr 2023 16:51 | UBX | Unity Biotechnology Inc | DANANBERG JAMIE | Chief Medical Officer | 31 Mar 2023 | Sale | 420 | 1.7 | 714 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)